Stock Earnings

Question 1

PTGX 最近的每股盈餘與預期相比如何？

Accepted Answer

Protagonist Therapeutics Inc 最近的每股盈餘為 $-0.62，not beating $-0.65 的預期。

Question 2

Protagonist Therapeutics Inc PTGX 上一季度的收入表現如何？

Accepted Answer

Protagonist Therapeutics Inc 上一季度的收入為 $-0.62

Question 3

Protagonist Therapeutics Inc 的收入預期是多少？

Accepted Answer

根據 14 位華爾街分析師的預測，Protagonist Therapeutics Inc 的收入預期範圍從 $236.25M 到 $0.0

Question 4

Protagonist Therapeutics Inc 的盈利品質評分是多少？

Accepted Answer

Protagonist Therapeutics Inc 的盈利品質評分為 B+/57.169914。該評分基於盈利能力、增長、現金生成與資本分配以及槓桿四個維度。

Question 5

Protagonist Therapeutics Inc 何時發布財報？

Accepted Answer

Protagonist Therapeutics Inc 的下一份財報預計在 2026-02-04 發布

Question 6

Protagonist Therapeutics Inc 的預期收益是多少？

Accepted Answer

根據華爾街分析師的預測，Protagonist Therapeutics Inc 的預期收益為 $3.7M

Question 7

Protagonist Therapeutics Inc 是否超出收益預期？

Accepted Answer

Protagonist Therapeutics Inc 最近的收益為 $4.71M，beat 預期。

Fiscal Period	Estimated	Reported	Surprise	Result
Q3 '25	$-0.65	$-0.62	-4.61%	MISSED
Q2 '25	$-0.59	$-0.55	-6.77%	MISSED
Q1 '25	$-0.23	$-0.19	-17.39%	MISSED
Q4 '24	$0.32	$1.98	+518.75%	BEAT
Q3 '24	$-0.61	$-0.54	-11.47%	MISSED

Protagonist Therapeutics Inc (PTGX) Price